Our Company | Diaceutics
  • Our Vision

    Better Testing. Better Treatment.
1
/
3
/

Who we are

Diaceutics is the diagnostic development and commercialization service provider.

What we do

We have been leading this field for 13 years, entirely focused on the intersection between diagnostics and therapeutic decision making. We provide an end to end service that encompasses everything from understanding the diagnostic landscape to test implementation in treatment pathways. This is all enabled by a robust flow of data from our global laboratory network.

What we stand for

Our ultimate goal is to drive better testing to enable better treatment decisions for patients.

Who we work with

source-bioscience
takeda
boehringer-ingelheim
novartis
bill-and-melinda-gates-foundation
roche
bluebirdbio
neo-genomics
merck
lilly
pfizer
promega
bristol-myers-squibb
bayer
abbvie
gsk
astellas
immunogen
celgene
amgen
incyte
daiichi-sankyo
gilead
astrazeneca
synlab
lexicon
ganymed

Our Vision

Partnering with stakeholders in healthcare globally to empower patients to receive better treatments through better testing.

Facebook
Twitter
YouTube
LinkedIn